Speakers

Co-Chairs

Dr. Leslie Fischer

Principal Patent Attorney
Sandoz (Princeton, NJ)

Co-Chairs’ Opening Remarks

August 5, 2020 • 9:00 am

Duane Marks

Assistant General Patent Counsel
Eli Lilly (Indianapolis, IN)

Section 101: Exploring the Realities of the New USPTO Guidance

August 5, 2020 • 2:00 pm

Speakers

Takanori Abe

Managing Partner
Abe & Partners (Osaka, Japan)

Written Description and Enablement in Antibody Arts: How Has the Scope of Claim Shifted in the U.S., Europe, and Japan?

August 5, 2020 • 11:20 am

Paki Banky

IP Litigation Counsel
Sandoz (Princeton, NJ)

Inherency and Obviousness: Anticipating What’s Next Around the World

August 5, 2020 • 4:30 pm

Honorable Jacqueline Bonilla

Vice Chief Administrative
Judge, Patent Trial and Appeal Board
U.S. Patent and Trademark Office
(Invited)

PTAB Keynote Address

August 5, 2020 • 9:15 am

Heather Boussios

Assistant General Counsel – IP
Aptevo Therapeutics (Seattle, WA)

Written Description and Enablement in Antibody Arts: How Has the Scope of Claim Shifted in the U.S., Europe, and Japan?

August 5, 2020 • 11:20 am

June Cohan

Legal Advisor, Office of Patent Legal Administration
U.S. Patent and Trademark Office (Alexandria, VA)

Section 101: Exploring the Realities of the New USPTO Guidance

August 5, 2020 • 2:00 pm

Nicola Dagg

Partner
Kirkland & Ellis (London, UK)

Written Description and Enablement in Antibody Arts: How Has the Scope of Claim Shifted in the U.S., Europe, and Japan?

August 5, 2020 • 11:20 am

Robin Ellis

Partner
Reddie & Grose GmbH

Exploring the Future of Patent Protection Through Artificial Intelligence

August 6, 2020 • 2:15 pm

James M. Gould

Counsel
Ratner Prestia (Philadelphia, PA)

Comparing and Contrasting Licensing Agreements in U.S. and Europe

August 6, 2020 • 9:15 am

Henry Gu

Head of Intellectual Property
Akebia Therapeutics (Cambridge, MA)

Focus on Small Molecules: Harnessing the Power of Written Description and Enablement to Strengthen Patent Protection in the U.S. – Europe – China

August 5, 2020 • 10:20 am

Charlotte Jacobson

Partner
Ropes & Gray (New York, NY)

Written Description and Enablement in Antibody Arts: How Has the Scope of Claim Shifted in the U.S., Europe, and Japan?

August 5, 2020 • 11:20 am

George Johnston

Counsel
Gibbons P.C. (Newark, NJ)
Former Vice President & Chief Patent Counsel, Hoffman-LaRoche

Comparing and Contrasting Licensing Agreements in U.S. and Europe

August 6, 2020 • 9:15 am

Tom Kowlaski

Partner
Duane Morris (New York, NY)

Ethical Obligations in Prosecution

August 6, 2020 • 3:00 pm

Forrester Liddle

Senior Director,
Head of Intellectual Property
Jounce Therapeutics (Cambridge, MA)

Inherency and Obviousness: Anticipating What’s Next Around the World

August 5, 2020 • 4:30 pm

Deborah Lu

Partner
Duane Morris (New York, NY)

Kevin E. Noonan, Ph. D.

Partner
McDonnell Boehnen Hulbert & Berghoff LLP (Chicago, IL)

Section 101: Exploring the Realities of the New USPTO Guidance

August 5, 2020 • 2:00 pm

Brendan M. O’Malley

Vice President, Chief IP Counsel
Abeona Therapeutics Inc (New York, NY)

Comparing and Contrasting Licensing Agreements in U.S. and Europe

August 6, 2020 • 9:15 am

Bert Oosting

Partner
Hogan Lovells (Amsterdam, NE)

Doctrine of Equivalents Analysis: Understanding How the Latest DoE Decisions Will Impact Future of Trends in Patent Law Protection in the U.S., Europe and Asia

August 6, 2020 • 11:00 am

Filko Prugo

Partner
Ropes & Gray (New York, NY)

Inherency and Obviousness: Anticipating What’s Next Around the World

August 5, 2020 • 4:30 pm

Roberto Rodrigues

Roberto Rodrigues

Attorney at Law
Licks Attorney (Rio de Janerio, BR)

Social Contracting: Understanding Its Impact on Patent Portfolio Design

August 6, 2020 • 1:00 pm

Christina Schwarz

Partner
Venable LLP (New York, NY)

Navigating the Evolving Obviousness-Type Double Patenting Landscape

August 5, 2020 • 3:40 pm

Marina Volin

VP, General Counsel and Corporate Secretary
Amring Pharmaceuticals (Berwyn, PA)

Navigating the Evolving Obviousness-Type Double Patenting Landscape

August 5, 2020 • 3:40 pm

Mark Waddle

Co-Chair, Life Sciences; Chair, Patent Litigation & Counseling
Loeb & Loeb LLP (New York, NY)

Section 101: Exploring the Realities of the New USPTO Guidance

August 5, 2020 • 2:00 pm